The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000
Postconditioning the Human Heart
Staat, P., Rioufol, G., Piot, C., Cottin, Y., Cung, T. T., L’Huillier, I., Aupetit, J.-F., Bonnefoy, E., Finet, G., André-Fouët, X., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.558122 · Cited by 999
Fishbein, M. C., Meerbaum, S., Rit, J., Lando, U., Kanmatsuse, K., Mercier, J. C., Corday, E., & Ganz, W. (1981) · American Heart Journal · doi:10.1016/0002-8703(81)90226-x · Cited by 930
Nikolaidis, L. A., Mankad, S., Sokos, G. G., Miske, G., Shah, A., Elahi, D., & Shannon, R. P. (2004) · Circulation · doi:10.1161/01.cir.0000120505.91348.58 · Cited by 901 · cited 1×
“Following AMI, an increased inotropy effect was noted in patients receiving GLP-1(7–36) amide infusion for up to 3 days after successful reperfusion [21].”
BackgroundGöke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., & Göke, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36565-2 · Cited by 837
Nyström, T., Gutniak, M. K., Zhang, Q., Zhang, F., Holst, J. J., Ahrén, B., & Sjöholm, Å. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00237.2004 · Cited by 680
Sokos, G. G., Nikolaidis, L. A., Mankad, S., Elahi, D., & Shannon, R. P. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.08.211 · Cited by 656
Glucagon-like Peptide 1 Can Directly Protect the Heart Against Ischemia/Reperfusion Injury
Bose, A. K., Mocanu, M. M., Carr, R. D., Brand, C. L., & Yellon, D. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.146 · Cited by 638
Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor
Bullock, B. P., Heller, R. S., & Habener, J. F. (1996) · Endocrinology · doi:10.1210/en.137.7.2968 · Cited by 618
Exon duplication and divergence in the human preproglucagon gene
Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C. (1983) · Nature · doi:10.1038/304368a0 · Cited by 593
Postconditioning Inhibits Mitochondrial Permeability Transition
Argaud, L., Gateau-Roesch, O., Raisky, O., Loufouat, J., Robert, D., & Ovize, M. (2005) · Circulation · doi:10.1161/01.cir.0000151290.04952.3b · Cited by 561
Nikolaidis, L. A., Elahi, D., Hentosz, T., Doverspike, A., Huerbin, R., Zourelias, L., Stolarski, C., Shen, Y.-T., & Shannon, R. P. (2004) · Circulation · doi:10.1161/01.cir.0000139339.85840.dd · Cited by 514
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection
Hausenloy, D. J., & Yellon, D. M. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9026-1 · Cited by 509
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers
Edwards, C. M. B., Stanley, S. A., Davis, R., Brynes, A. E., Frost, G. S., Seal, L. J., Ghatei, M. A., & Bloom, S. R. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.1.e155 · Cited by 464
Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process
Moens, A. L., Claeys, M. J., Timmermans, J. P., & Vrints, C. J. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.04.013 · Cited by 448
Vilsbøll, T., Agersø, H., Krarup, T., & Holst, J. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021053 · Cited by 444 · cited 1×
“In dogs with dilated cardiomyopathy treated with GLP-1(9–36) amide, improvement of left ventricular performance occurred between 6 and 48 h of treatment and persisted for at least 24 h after its cessation [28], despite the plasma half-life of 3–5 min for this peptide [33].”
BackgroundGlucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig
Deacon, C. F., Pridal, L., Klarskov, L., Olesen, M., & Holst, J. J. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.3.e458 · Cited by 299
Nikolaidis, L. A., Elahi, D., Shen, Y.-T., & Shannon, R. P. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00347.2005 · Cited by 274
Knudsen, L. B., & Pridal, L. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00795-9 · Cited by 248
Rouillé, Y., Martin, S., & Steiner, D. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26488 · Cited by 245
Glucagon-like peptide-1: From extract to agent. The Claude Bernard Lecture, 2005
Holst, J. J. (2006) · Diabetologia · doi:10.1007/s00125-005-0107-1 · Cited by 228
Cardiac Function in Mice Lacking the Glucagon-Like Peptide-1 Receptor
Gros, R., You, X., Baggio, L. L., Kabir, M. G., Sadi, A. M., Mungrue, I. N., Parker, T. G., Huang, Q., Drucker, D. J., & Husain, M. (2003) · Endocrinology · doi:10.1210/en.2003-0007 · Cited by 193
Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism
Nyström, T., Gonon, A. T., Sjöholm, Å., & Pernow, J. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.024 · Cited by 188 · cited 2×
“GLP-1(7–36) amide was found to relax femoral artery rings [19].”
BackgroundLaskey, W. K. (2005) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.20397 · Cited by 182
Vila Petroff, M. G., Egan, J. M., Wang, X., & Sollott, S. J. (2001) · Circulation Research · doi:10.1161/hh1701.095716 · Cited by 180
Barragan, J. M., Rodriguez, R. E., & Blazquez, E. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.3.e459 · Cited by 176
GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor
Yang, H. M., Egan, J. M., Wang, Y., Moyes, C. D., Roth, J., Montrose, M. H., & Montrose‐Rafizadeh, C. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.3.c675 · Cited by 145
Preconditioning, postconditioning and their application to clinical cardiology
Kloner, R. A., & Rezkalla, S. H. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.012 · Cited by 132
Bose, A., Mocanu, M. M., Carr, R. D., & Yellon, D. M. (2005) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-005-6892-4 · Cited by 127
Bose, A., Mocanu, M. M., Carr, R. D., & Yellon, D. M. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6030-6 · Cited by 123
MA, X., Zhang, X., Li, C., & LUO, M. (2006) · Journal of Interventional Cardiology · doi:10.1111/j.1540-8183.2006.00191.x · Cited by 114
The pathophysiology of myocardial reperfusion: a pathologist’s perspective
Basso, C., & Thiene, G. (2006) · Heart · doi:10.1136/hrt.2005.086959 · Cited by 107
Deacon, C. F., Plamboeck, A., Møller, S., & Holst, J. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00452.2001 · Cited by 104
Amsterdam, E. A., Hughes, J. L., DeMaria, A. N., et al. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90214-8 · Cited by 79
Wettergren, A., Wøjdemann, M., & Holst, J. J. (1998) · Peptides · doi:10.1016/s0196-9781(98)00020-5 · Cited by 67
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“While these studies suggest that GLP-1 influx into the brain might be a GLP-1R-independent process with passive diffusion of GLP-1 through the BBB [750e752], other studies suggest that uptake of liraglutide into the brain is GLP-1R-dependent [686,753].”
BackgroundResultInfluentialGLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
Meier, J. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.140 · Cited by 1,311
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“More recently, studies using isolated, perfused rat heart have also shown that GLP-1R agonists protect the heart against myocardial ischemicreperfusion injury (Bose et al., 2007; Huisamen et al., 2008; Sonne et al., 2008), and this protection is blocked by Ex-9-39 (Sonne et al., 2008).”
BackgroundResultInfluentialNoyan-Ashraf, M. H., Momen, M. A., Ban, K., Sadi, A.-M., Zhou, Y.-Q., Riazi, A. M., Baggio, L. L., Henkelman, R. M., Husain, M., & Drucker, D. J. (2009) · Diabetes · doi:10.2337/db08-1193 · Cited by 575
“The GLP-1 metabolite, GLP-1, also exerts cardioprotective actions when administered postischemia (3,16), further highlighting the complexity of different GLP-1–related peptides on the ischemic heart.”
BackgroundInfluentialExenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
Lønborg, J., Vejlstrup, N., Kelbæk, H., Bøtker, H. E., Kim, W. Y., Mathiasen, A. B., Jørgensen, E., Helqvist, S., Saunamäki, K., Clemmensen, P., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr309 · Cited by 550
Self-citation
Metadata
- Authors
- Sonne, D. P., Engstrøm, T., & Treiman, M.
- Venue
- Regulatory Peptides
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 146
- Issue
- 1-3
- Pages
- 243-249
- ISSN
- 0167-0115 (ISSN-L)
- OpenAlex
- W2072935519
- Cited by
- 294
- References
- 35
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.